Abstract:Serotonin 1A receptor (5-HT1AR) is a clinically relevant target because of its involvement in several central and peripheral functions, including sleep, temperature homeostasis, processing of emotions, and response to stress. As a G protein coupled receptor (GPCR) activating numerous Gα i/o/z family members, 5-HT1AR can potentially modulate multiple intracellular signaling pathways in response to different therapeutics. Here, we applied a cell-based bioluminescence resonance energy transfer assay to quantify how ten structurally diverse 5-HT1AR agonists exert biased signaling by differentially stimulating Gα i/o/z family members. Our concentration-response analysis of the activation of each Gα i/o/z protein revealed unique potency and efficacy profiles of selected agonists when compared with the reference 5-hydroxytryptamine, serotonin. Overall, our analysis of signaling bias identified groups of ligands sharing comparable G protein activation selectivity and also drugs with unique selectivity profiles. We observed, for example, a strong bias of F-15599 toward the activation of Gα i3 that was unique among the agonists tested: we found a biased factor of +2.19 when comparing the activation of Gα i3 versus Gα i2 by F-15599, while it was -0.29 for 8-hydroxy-2-(di-n-propylamino) tetralin. Similarly, vortioxetine showed a biased factor of +1.06 for Gα z versus Gα oA, while it was -1.38 for vilazodone. Considering that alternative signaling pathways are regulated downstream of each Gα protein, our data suggest that the unique pharmacological properties of the tested agonists could result in multiple unrelated cellular outcomes. Further investigation is needed to reveal how this type of ligand bias could affect cellular responses and to illuminate the molecular mechanisms underlying therapeutic profile and side effects of each drug. SIGNIFICANCE STATEMENT: Serotonin 1a receptor (5-HT1AR) activates several members of the Gi/o/z protein family. Here, we examined ten structurally diverse and clinically relevant agonists acting on 5-HT1AR and identified distinctive bias patterns among G proteins. Considering the diversity of their intracellular effectors and signaling properties, this data reveal novel mechanisms underlying both therapeutic and undesirable effects.

Molecular, pharmacological and functional diversity of 5-HT receptors

Molecular biology of 5-HT receptors

Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation

The discovery, structure, and function of 5-HTR1E serotonin receptor

Embracing diversity in the 5-HT neuronal system

GPCRs steer G<sub>i</sub> and G<sub>s</sub> selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors

A review of central 5-HT receptors and their function

5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome

Structure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor

Targeting the 5-HT system: Potential side effects

5-HT Receptor-Associated Protein Networks: New Targets for Drug Discovery in Psychiatric Disorders?

Structure, dynamics and lipid interactions of serotonin receptors: excitements and challenges

Modern 5-HT receptor classification and 5-HT based drugs

5-HT Receptor Regulation of Neurotransmitter Release

Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey

5-HT Receptors and the Development of New Antidepressants

Structural Basis for Molecular Recognition at Serotonin Receptors

Structural insights into the lipid and ligand regulation of serotonin receptors

G α Protein Signaling Bias at Serotonin 1A Receptor